Beiersdorf Lifts Guidance After Robust Nivea Sales
By Michael Susin
Beiersdorf upgraded its full-year expectations after reporting a robust sales increase during the first quarter, driven by Nivea cream.
The German personal-care products maker on Tuesday said it now expects organic sales growth for 2024 of 6% to 8%, compared with its previous target of mid-single-digit growth.
It continues to expect an earnings before interest and taxes margin slightly above last year's 13.4%.
Group total sales for the first quarter rose 2.6% to 2.6 billion euros ($2.76 billion).
Organic sales at its consumer segment--Beiersdorf's core business, which focuses on skin and body care products--rose by 10% to EUR2.2 billion, driven by Nivea cream sales, which increased by 13%. The business reported growth across all regions, especially in Europe and the emerging markets.
"Nivea also achieved its best quarter ever in terms of absolute value in the first quarter," Chief Executive Vincent Warnery said. "At the same time, our Derma business contributed solid double-digit growth, and the luxury business is on its way toward the expected full turnaround after a challenging year 2023."
However, sales at its Tesa adhesive business fell 5.4% to EUR397 million.
Write to Michael Susin at michael.susin@wsj.com
(END) Dow Jones Newswires
April 16, 2024 02:14 ET (06:14 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits
-
Novo Nordisk Earnings: Raised Fair Value Estimate Still a Contrast to Market Overenthusiasm
-
After Earnings, Is Verizon Stock a Buy, a Sell, or Fairly Valued?
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
How to Invest Like Warren Buffett
-
Cognizant Earnings: Improved Profitability Buttresses Results as Customer Spending Remains Muted
-
10 Top-Performing Dividend Stocks of the Month